IN-OFFICE AND IN-HOME NEUROCOGNITIVE TESTING PROC
The primary function is to measure, for the purpose of detecting, even slight to early cognitive impairments and identify symptoms, behaviors and comorbidities. Secondly, is to augment data generated from the clinical history, the examination and other tests to assist in the evaluation of cognitive status. Thirdly, to longitudinally track cognitive function; i.e. manage and monitor patient outcomes.
The platform has over 7000 clinician users in 52 countries, it is also used by the military and VA, many academic medical centers/hospitals, most major pharmaceutical companies (over 2200 investigator sites world-wide), to assess neurocognition in the following clinical conditions:
ADULT NEUROCOGNITIVE ASSESSMENT... When medically necessary, our platform can perform the needed BRIEF-CORE NEUROCOGNITIVE TEST. Testing with the CNS platform can help identify the need for other psychological testing. These tests are widely reimbursed by both Medicare and Private Carriers. Aditionally, we have found that patients are also willing to pay out-of-pocket to have their neurocognitive function measured.
CHILDREN & ADOLESENT ASSESSMENT... The CNS platform has a comprehensive set of tools to SCREEN and ASSESS adolescent patients for conditions such as AD/HD etc.
RATING SCALES: e.g., SUBSTANCE ABUSE -SBIRT Screening... The CNS platform has a comprehensive set of rating scale tools to assess patients for many conditions e.g., collect data or clinical endpoints for your Substance Abuse PQRS needs.
Practice marketing support and patient education tools are available from Jefferson Healthcare to help you maximize your patient and practice experience.